$5.10 $0.08 per serving
Product analysis
Melatonin Lozenges 3 mg offers favorably priced melatonin that may help with sleep timing and falling asleep. Its usefulness depends on when it is taken and the person's sleep pattern.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The melatonin preparation is unspecified, limiting a firm quality comparison. The lozenge format alone does not establish a delivery advantage.
Ingredient Transparency63
The amounts are disclosed, but the forms are unspecified. Serving sizes can be compared more readily than preparation quality.
Value For Money85
The declared active content is favorably priced in the comparison. That supports value when the ingredient matches your needs.
Customer Satisfaction85
Customer ratings are favorable, with a substantial review pool. Reviews describe satisfaction without establishing effectiveness or safety.
Product Focus71
Sleep timing and onset are the clearest uses. The sleep-related role does not establish broader immune, memory or everyday-health benefits.
- Format
Lozenge - Container
- 60 Liquid(s)
- Per serving
- $0.08
- Customer rating
- 4.7 · 2,483 ratings
Goals
Impact
Highest effect
Melatonin · 3 mg
Impact
Moderate effect
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Melatonin | 3 mg |
Melatonin · 3 mg OverallScore57
Each serving provides 3 mg of melatonin, a lower amount aligned with the stated natural sleep-cycle range, at a fairly low cost per serving. No manufacturing or independent testing claim is available in the information provided.
How this ingredient is rated
Active Ingredient Quality & Bioavailability0
No manufacturing or independent testing claim is available in the information provided.
Third-Party Purity Verification
No manufacturing or independent testing claim is available in the information provided.
Dose, Safety & Label Transparency100
A serving provides 3 mg of melatonin, a lower amount aligned with the stated natural sleep-cycle range.
Physiological Dosing Alignment
The serving contains 3 mg of melatonin, a lower amount aligned with the stated natural sleep-cycle range.
Value85
The cost per serving is fairly low.
Price Per Serving Efficiency
The cost per serving is fairly low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
- Melatonin for sleep and cognitive outcomes in older adults with cognitive impairment: a meta-analysis of randomised controlled trials.
- Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
- Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule.
- Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Melatonin for preventing and treating jet lag.
- Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
- Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials.
- Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses.
- Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial.
- Exogenous melatonin boosts vaccine-induced immunity in individuals with high pre-existing influenza immunity.
- Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
- Pineal-opioid system interactions in the control of immunoinflammatory responses.
- Influenza vaccine response is predicted by chronotype and differentially associated with pre- and post-vaccination sleep.
- Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.
- Meta-analysis: melatonin for the treatment of primary sleep disorders.
- Melatonin treatment for age-related insomnia.
- The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
- Effects of exogenous melatonin on sleep: a meta-analysis.